CDEK
← Mechanisms of action

CD276

SINGLE PROTEINHomo sapiens
Preferred name: CD276 antigen ChEMBL ↗

Linked proteins

Drugs acting on this target (57)

Active Pharmaceutical Ingredient Mechanism Type ▲ Approval Status API Type Mechanism of Action
tj271AntagonistexperimentalmAbB7H3
7mw3711Binding agentexperimentalmAbCD276 binding agent
bat8009Binding agentexperimentalmAbB7H3
cc-3Binding agentexperimentalmAbCD276 binding agent
db-1311Binding agentexperimentalmAbCD276 binding agent
hs-20093Binding agentexperimentalmAbB7-H3
mhb088cBinding agentexperimentalmAbB7H3
tak-280BufferexperimentalmAbCD276 buffer
enoblituzumabCross-linking agentexperimentalmAbCD276 cross-linking agent
b7.1/il-2Immunity, activeexperimentalVaccineCD276 immunity, active
4scar-276Immunity, passiveexperimentalCell therapyCD276 immunity, passive
autologous CD276 car-T cellsImmunity, passiveexperimentalCell therapyCD276 immunity, passive
b7-h3 car-tImmunity, passiveexperimentalCell therapyCD276 immunity, passive
b7-h3 target, car gene modified gdt cell injectionImmunity, passiveexperimentalCell therapyCD276 immunity, passive
b7h3 specific car t cell with il-7ra signaling domainImmunity, passiveexperimentalCell therapyCD276 immunity, passive
car.b7-h3Immunity, passiveexperimentalCell therapyCD276 immunity, passive
dit309Immunity, passiveexperimentalCell therapyCD276 immunity, passive
epc-003Immunity, passiveexperimentalCell therapyCD276 immunity, passive
gd2, psma and cd276 car-t cellsImmunity, passiveexperimentalCell therapyCD276 immunity, passive
ic9-car.b7-h3 t cellsImmunity, passiveexperimentalCell therapyCD276 immunity, passive
kt095Immunity, passiveexperimentalCell therapyCD276 immunity, passive
mt027Immunity, passiveexperimentalCell therapyCD276 immunity, passive
qh104Immunity, passiveexperimentalCell therapyCD276 immunity, passive
sc-car4brainImmunity, passiveexperimentalCell therapyCD276 immunity, passive
scri-carb7h3Immunity, passiveexperimentalCell therapyCD276 immunity, passive
taa06Immunity, passiveexperimentalCell therapyCD276 immunity, passive
tils and car-tils targeting her2, mesothelin, psca, muc1, lewis-y, gpc3, axl, egfr, claudin18.2/6, ror1, gd1, or b7-h3Immunity, passiveexperimentalCell therapyCD276 immunity, passive
tx103Immunity, passiveexperimentalCell therapyCD276 immunity, passive
wl276 car-t cellsImmunity, passiveexperimentalCell therapyCD276 immunity, passive
[68ga] b7h3 affibody-bchInhibitorexperimentalmAbCD276 inhibitor
131 i-omburtamabInhibitorexperimentalmAbCD276 inhibitor
177lu-dtpa-omburtamabInhibitorexperimentalmAbCD276 inhibitor
b7-h3.cd28z.cartInhibitorexperimentalCell therapyCD276 inhibitor
b7h3-il7ra car-t cellsInhibitorexperimentalCell therapyCD276 inhibitor
b7h3-irdye800cwInhibitorexperimentalmAbCD276 inhibitor
bgb-c354InhibitorexperimentalmAbCD276 inhibitor
db-1419InhibitorexperimentalmAbCD276 inhibitor
ds-5573aInhibitorexperimentalmAbCD276 inhibitor
dxc014InhibitorexperimentalmAbCD276 inhibitor
enoblituzumabInhibitorexperimentalmAbCD276 inhibitor
gensci143InhibitorexperimentalmAbCD276 inhibitor
ibb0979InhibitorexperimentalRecombinant proteininhibitor - CD276
ibi129InhibitorexperimentalmAbCD276 inhibitor
ibi3001InhibitorexperimentalmAbCD276 inhibitor
ibi334InhibitorexperimentalmAbCD276 inhibitor
icp-b794InhibitorexperimentalmAbCD276 inhibitor
ifinatamab deruxtecanInhibitorexperimentalmAbCD276 inhibitor
ilb-3101InhibitorexperimentalmAbCD276 inhibitor
mgc018InhibitorexperimentalmAbCD276 inhibitor
mgc026InhibitorexperimentalmAbCD276 inhibitor
mgd009InhibitorexperimentalmAbCD276 inhibitor
Mirzotamab clezutoclaxInhibitorexperimentalmAbCD276 inhibitor
qlc5508InhibitorexperimentalmAbCD276 inhibitor
sys6043InhibitorexperimentalmAbCD276 inhibitor
xmab®808InhibitorexperimentalmAbCD276 inhibitor
yl211InhibitorexperimentalmAbCD276 inhibitor
177lu-betabartRadiodepletionexperimentalmAbCD276 radiodepletion